The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers. Unfortunately, it is not yet possible to monitor biomarkers live in patients when these are present in minuscule concentrations. Researchers at Eindhoven University of Technology have now developed a new technique that can become the plain and simple solution for the live and super-sensitive monitoring of biomarkers.
They report on it in Nature Communications.
Substances that are essential for the body, such as proteins and hormones, are present in the blood in pico- or nanomolar concentrations. These are concentrations comparable to 1 sugar grain dissolved in an Olympic-sized swimming pool – extremely low, and difficult to measure. In the Molecular Biosensing for Medical Diagnostics group at Eindhoven University of Technology, under the guidance of Professor Menno Prins, a sensing technology has been developed that enables the super-sensitive measurement of biomarker concentrations over time.
The technique is based on the fact that tiny particles in liquid are continuously in Brownian motion because water molecules collide with them. The researchers bound the particles through a nanostrand to a glass plate, causing the particles to wiggle back and forth. The biomarker to be measured binds temporarily to specific adhesive molecules that are fixed to both the particles and the plate. When a biomarker molecule attaches itself to both a wiggling particle and to the plate, the particle suddenly becomes attached, which greatly reduces its mobility – until the biomarker is released again.
The mobility of the particles, which are coupled to the transparent glass, could be easily observed by the researchers with light. They have given their technology the name BPM: Biomarker monitoring based on sensing of Particle Mobility. Every time a wiggling particle suddenly moves less, and then more, one biomarker molecule has been observed. The number of these events per minute reveals the concentration of the biomarker in the liquid with a high degree of sensitivity.
The principle is explained in this animation video: https:/
The beauty of the BPM sensor technology is that it has digital precision, and that both increases and decreases in biomarker concentration over time can be monitored. The technique has now been demonstrated for the monitoring of protein and DNA. The technology is widely applicable, because suitable adhesion molecules are available for almost all biomarkers.
This flexibility, combined with the sensitivity and the expected miniaturization of the technology, means that Prins and his fellow researchers have high expectations of the future for their technology. “We anticipate that a completely new class of sensors for the monitoring of biomarkers will emerge from this,” says the professor, so he is creating a start-up that will develop practical sensors and applications. One of the possibilities is to connect a sensor to a catheter with which patients in the operating room or in the intensive care unit can be accurately monitored. In addition to medical applications, Prins also thinks there are possibilities for monitoring biomolecules in industrial processes and water purification.
Learn more: New sensor technology enables super-sensitive live monitoring of human biomolecules
The Latest on: Monitoring of biomarkers
[google_news title=”” keyword=”monitoring of biomarkers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Monitoring of biomarkers
- 6.7 million Americans at risk of genetic Alzheimer's with 95% strike rateon May 8, 2024 at 3:22 am
Because almost all APOE4 homozygotes revealed "near-full penetrance" of the disease's pathology and biomarkers, the researchers now ... "The findings emphasize the importance of monitoring APOE4 ...
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Reviewon May 8, 2024 at 12:25 am
“We are pleased to report that the Data Monitoring Committee for our ATH434-201 Phase 2 ... trial is evaluating the effect of ATH434 treatment on neuroimaging and protein biomarkers to demonstrate ...
- Researchers use foundation models to discover new cancer imaging biomarkerson May 7, 2024 at 1:25 pm
Researchers have harnessed the technology behind foundation models, which power tools like ChatGPT, to discover new cancer imaging biomarkers that could transform how patterns are identified from ...
- A new form of Alzheimer's has been discovered: it is linked to a gene, here's who is most at riskon May 7, 2024 at 5:47 am
A team of Spanish researchers from the Sant Pau Research Institute in Barcelona has discovered a new form of Alzheimer's with an “incriminating” gene. In the study published in the scientific journal ...
- Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatmenton May 7, 2024 at 4:00 am
Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced study results published as a preprint on bioRXiv demonstrating the potential for ...
- Association of inflammatory and metabolic biomarkers and accelerated aging in cardiac catheterization patientson May 6, 2024 at 4:59 pm
A new research paper was published in Aging, entitled, “Associations among NMR-measured inflammatory and metabolic biomarkers and accelerated aging in cardiac catheterization patients.” ...
- Biomarkers Market Projected to Reach Valuation of USD 134.2 Billion at 11.2% CAGR from 2024-2033on May 6, 2024 at 8:30 am
What is the size of the biomarker market in the world?According to the report, the global biomarkers market size was valued at $46.4 billion in 2023, and is projected to reach $134.2 billion by 2033, ...
- HE4 as a Biomarker for Ovarian and Endometrial Cancer Managementon May 3, 2024 at 5:01 pm
Researchers have been vigorously working on the identification of a more reliable biomarker to assist in early detection, as well as treatment- and general disease-monitoring. HE4 is among the ...
- The Apple Watch Is Now Qualified for Clinical AFib Monitoringon May 2, 2024 at 2:30 pm
The Apple Watch’s ability to detect atrial fibrillation (AFib) is one of its most celebrated life-saving features, and multiple studies have shown it’s amazingly accurate. Now, the US Food and Drug ...
via Bing News